Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations
  4. 5 Insider Annual Insider Trading Report
  5. 4 Open-market sale President and CEO sold 9,491 shares at $34.72 ($329,528)
  6. 4 Open-market sale CFO and Treasurer sold 2,560 shares at $34.69 ($88,806)
  7. 4 Open-market sale COO and Secretary sold 2,803 shares at $34.68 ($97,208)
  8. 4 Open-market sale Chief Medical Officer sold 2,918 shares at $34.71 ($101,284)
  9. 3/A Insider 3/A
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Regulation FD disclosure
  13. 4 Open-market sale CFO and Treasurer sold 1,296 shares at $37.09 ($48,073)
  14. 4 Open-market sale President and CEO sold 2,719 shares at $37.55 ($102,104)
  15. 4 Open-market sale COO and Secretary sold 1,423 shares at $37.10 ($52,800)
  16. 4 Open-market sale Chief Medical Officer sold 1,423 shares at $37.10 ($52,791)
  17. 8-K Event Other events
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 20 of 40 · 789 filings